Beat Childhood Cancer Specimen Banking and Data Registry
Specimen Banking With Clinical and Genomic Data Registry With the Establishment of Tumor Models for Pediatric Cancers
1 other identifier
observational
1,000
1 country
18
Brief Summary
This is an observational data registry study of pediatric cancer patients at participating Beat Childhood Cancer Consortium sites involving specimen banking and data collection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2021
Longer than P75 for all trials
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 15, 2021
CompletedFirst Posted
Study publicly available on registry
January 20, 2021
CompletedStudy Start
First participant enrolled
February 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2032
February 3, 2026
January 1, 2026
9.9 years
January 15, 2021
January 30, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Create a data registry of clinical and molecular/genomic data
Create a data registry of clinical and molecular/genomic data from cancer patients who have undergone biopsy or surgical resection for clinical care to better understand the relationship between genomic and molecular information and clinical outcomes.
10 Years
Determine number and types of genomic alterations within tumor types/subtypes
Define genomic landscape of pediatric cancers through the determination of the number and types of genomic alterations within tumor types/subtypes, across tumor types, and tumor evolution over time.
10 Years
Evaluate the rate of actionable genomic alternations
Evaluate the rate of actionable genomic alternations resulting in associated targeted therapies relative to all actionable genomic alterations.
10 Years
Evaluate the correlation of baseline genomic alterations with clinical outcome.
Evaluate the correlation of baseline genomic alterations with clinical outcome.
10 Years
Identify biomarkers that predict risk of adverse outcomes that occur following pediatric cancer therapy.
Identify biomarkers that predict risk of adverse outcomes that occur following pediatric cancer therapy.
10 Years
Secondary Outcomes (4)
Bank additional specimens available for future research projects
10 Years
Develop cell line and xenograft models of pediatric cancers for future research
10 Years
Identify biomarkers that predict risks of disease states in subject controls that did not receive cancer therapy.
10 Years
Identify biomarkers that may predict risk of disease dependent on sex, race, ethnicity, or the presence of comorbidities.
10 Years
Study Arms (1)
Patients with suspected or confirmed pediatric solid tumors
Patients with suspected or confirmed pediatric solid tumors
Interventions
No intervention- registry only
Eligibility Criteria
Pediatric cancer subjects, survivorship, and healthy volunteers at The Pennsylvania State University and participating Beat Childhood Cancer Research Consortium sites.
You may qualify if:
- No age restrictions
- Subjects that fit into one of the following categories:
- Subjects with suspected or confirmed cancers of childhood, adolescence, or young adulthood.
- Survivors of a cancer of childhood, adolescence, or young adulthood (\> 6 months off last therapy for cancer)
- Subjects with a disease-matched condition
- Healthy volunteers- including any participants with medical conditions that are not disease-matched.
- Written informed consent in accordance with institutional and FDA guidelines must be obtained from all subjects (or subjects' legal representative).
You may not qualify if:
- Subject or his/her legally authorized representative (where applicable) did not consent for specimen banking and data collection for this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Giselle Shollerlead
Study Sites (18)
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
Rady Children's Hospital
San Diego, California, 92123, United States
Connecticut Children's Hospital
Hartford, Connecticut, 06106, United States
Nicklaus Children's Miami
Miami, Florida, 33155, United States
Arnold Palmer Hospital for Children
Orlando, Florida, 32806, United States
St. Joseph's Children's Hospital
Tampa, Florida, 33614, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine
Louisville, Kentucky, 40292, United States
Children's Hospital and Clinics of Minnesota
Minneapolis, Minnesota, 55404, United States
Children's Mercy Hospitals and Clinics
Kansas City, Missouri, 64108, United States
Cardinal Glennon Children's Hospital
St Louis, Missouri, 63104, United States
Levine Children's Hospital
Charlotte, North Carolina, 28204, United States
AH Wake Forest Baptist - Brenner Children's Hospital
Winston-Salem, North Carolina, 27157, United States
Randall Children's Hospital
Portland, Oregon, 97227, United States
Penn State Milton S. Hershey Medical Center and Children's Hospital
Hershey, Pennsylvania, 17033, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Dell Children's Blood and Cancer Center
Austin, Texas, 78723, United States
Children's Hospital of The King's Daughters
Norfolk, Virginia, 23507, United States
Related Links
Biospecimen
whole blood, serum, urine, bone marrow, CSF, bucal swabs, tissue
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Giselle Sholler, MD
Beat Childhood Cancer
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Beat Childhood Cancer Chair
Study Record Dates
First Submitted
January 15, 2021
First Posted
January 20, 2021
Study Start
February 2, 2021
Primary Completion (Estimated)
January 1, 2031
Study Completion (Estimated)
January 1, 2032
Last Updated
February 3, 2026
Record last verified: 2026-01